about
The Promise of Preventive Cancer VaccinesCancer vaccines: state of the art of the computational modeling approachesThe Association between Dystemperament and Prevention of Diseases: A Systematic ReviewModeling the competition between lung metastases and the immune system using agents.Optimal vaccination schedule search using genetic algorithm over MPI technologyMathematical modeling of the immune system recognition to mammary carcinoma antigen.Placenta-derived gp96 as a multivalent prophylactic cancer vaccine.Preclinical HER-2 Vaccines: From Rodent to Human HER-2Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.Preclinical vaccines against mammary carcinoma.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer.Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate.Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic mice.HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic responseTherapeutic Cancer Vaccines: How Much Closer Are We?Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.The pulse vaccination effects in mammary carcinoma
P2860
Q26783742-D62D048B-D01A-48B2-8647-2CAC8A62D90FQ26825044-3118228C-F985-4594-9A97-8B18FC186D88Q28070147-100150AA-E632-41AB-A5FF-C9E3E63F3245Q33755575-F2490E8A-8639-402C-B5A0-3C7532E94E12Q34475889-DF5D00F2-FB17-4CDD-96C3-91EC7DA410A6Q34529999-592408BF-E391-45B9-A455-EAB016D73D09Q36907244-32F49846-13ED-43F7-B812-9BE08F2BFB6DQ36914661-AE47FFCD-0DDF-4ADF-A5A5-7C79E6E6B4ACQ37294327-ED46C4D8-4DF0-4959-A176-43E3DCBA18D4Q37321696-AA3A2598-8297-4DD4-B42D-37DDF676316CQ37691212-36A41F89-640F-4DC4-9DCF-19DC30A49120Q38160252-D1692F71-1BE6-4210-8395-6F8FFA80CD20Q38473314-61DBDB10-918A-45D3-9728-BF2DBDAFF1ADQ39289206-62E8863B-0544-4A40-8C21-67EC99C11E5DQ39359136-78254B6D-FCF6-435C-A037-DF2E346EE87DQ39816984-A80809FC-9681-4F1A-B0B5-F13D384B7BE1Q41551956-47874E9E-938E-4241-B475-02232F201AC8Q47235984-76AB990D-D713-410F-877D-B69D3C84BE99Q51741261-7521FA67-DAF9-4F03-9979-6A8709109196Q59275322-4CC9F3BB-5FC3-4C3A-9806-EE462B06C2D9
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antimetastatic Activity of a Preventive Cancer Vaccine
@ast
Antimetastatic Activity of a Preventive Cancer Vaccine
@en
type
label
Antimetastatic Activity of a Preventive Cancer Vaccine
@ast
Antimetastatic Activity of a Preventive Cancer Vaccine
@en
prefLabel
Antimetastatic Activity of a Preventive Cancer Vaccine
@ast
Antimetastatic Activity of a Preventive Cancer Vaccine
@en
P2093
P50
P1433
P1476
Antimetastatic activity of a preventive cancer vaccine
@en
P2093
Annalisa Murgo
Arianna Palladini
Carla De Giovanni
Giordano Nicoletti
Lorena Landuzzi
Marina Fabbi
Piero Musiani
P304
11037-11044
P356
10.1158/0008-5472.CAN-07-2499
P407
P577
2007-11-01T00:00:00Z